viru
highlight
rapid
respons
scientif
commun
previous
unknown
global
pathogen
advanc
synthet
organ
chemistri
molecular
biolog
informat
made
possibl
vitro
vivo
term
chemic
genet
coin
signifi
use
chemic
depart
microbiolog
depart
biochemistri
turb
systemat
thu
determin
function
protein
way
mutat
use
classic
genet
decid
dissect
pathogen
pathway
sarscov
use
chemic
pokfulam
hong
kong
sar
china
genet
hypothes
use
forward
chemic
genet
small
molecul
aaron
diamond
aid
research
center
first
avenu
duce
alter
phenotyp
cell
organ
identifi
cellular
target
determin
new
york
new
york
subsequ
abl
isol
novel
smallmolecul
compound
perturb
biolog
pathway
essenti
pathogenesi
sarscov
summari
sever
acut
respiratori
syndromeassoci
tion
intern
target
coronaviru
sarscov
infect
cell
sarscov
undergo
rapid
replic
cypeopl
across
countri
caus
cle
seri
concert
transcript
translafat
base
concept
chemic
genet
tional
posttransl
proteolyt
process
screen
structur
divers
small
moleev
lead
matur
releas
infect
cule
identifi
compound
viral
particl
cultur
supernat
antisarscov
activ
compound
specul
variou
biolog
pathway
intarget
sarscov
main
proteas
pro
target
volv
viral
pathogenesi
could
perturb
small
helicas
hel
target
spike
proteinangiomolecul
use
chemic
genet
approach
extensinconvert
enzym
mediat
viral
enamin
feasibl
employ
chemic
genet
tri
ec
major
compound
approach
sarscov
research
acquir
determin
sarscov
plaqu
reduct
assay
chemic
librari
chembridg
corpor
found
low
micromolar
rang
three
sestructur
divers
smallmolecul
compound
lect
compound
valivari
function
group
charg
sarsdat
inhibitor
sarscov
pro
hel
viral
cov
replic
effect
vero
cell
african
green
entri
respect
exhibit
potent
antivir
activ
monkey
kidney
cell
line
full
cytopath
effect
cpe
ec
compar
inhibitori
activ
infect
cell
observ
within
hr
postintargetspecif
vitro
assay
fection
vero
cell
cpe
use
phenotyp
indic
success
viral
infect
cellbas
assay
introduct
screen
smallmolecul
compound
perturb
infect
viru
employ
highthroughput
sever
acut
respiratori
syndromeassoci
coscreen
ht
technolog
gener
collect
ronaviru
sarscov
recent
emerg
causof
structur
divers
smallmolecul
compound
per
agent
endem
atyp
pneumonia
within
turb
pathogenesi
sarscov
lay
year
sarscov
infect
peopl
foundat
dissect
molecular
basi
viral
across
countri
cost
human
live
infect
use
chemic
genet
lack
knowledg
novel
coronaviru
sarscov
absenc
efficaci
therapeut
agent
main
reason
failur
manag
result
discuss
outbreak
sar
effect
caus
agent
devast
diseas
identifi
us
primari
screen
gml
compound
rapidli
sever
group
subsequ
revers
identifi
hit
hit
rate
protect
genet
sarscov
cdna
accomplish
vero
cell
sarscovinduc
cpe
hit
identifi
function
receptor
rearray
concentr
select
compound
lower
gml
secondari
screen
compound
retain
consist
protect
ef
correspond
rytkao
hkucchkuhk
schemat
illustr
major
process
involv
phenotypebas
screen
shown
enlarg
imag
vero
cell
typic
tissu
cultur
plate
use
screen
also
includ
indic
criteria
hit
select
compound
fulli
protect
vero
cell
sarscovinduc
cpe
select
hit
fect
sarscovinduc
cpe
vero
cell
viral
pro
purifi
sarscov
pro
cleav
effici
specif
synthet
peptid
figur
evalu
quantit
plaqu
reduct
assay
demonstr
ec
median
efsequ
h
mimick
put
autolyt
cleavag
site
cleavag
site
indifect
concentr
select
compound
gml
compound
ec
cate
ntermin
part
pro
screen
compound
concentr
gml
gml
subsequ
studi
concentr
select
compound
convert
molar
identifi
two
candid
potenti
inhibitor
sarscov
pro
one
compound
design
unit
precis
comparison
biolog
activ
tc
median
toxic
concentr
display
potent
inhibitori
activ
ic
median
inhibitori
concentr
figur
lect
compound
determin
mtt
ec
vero
cellbas
sarscov
plaqu
reduct
assay
figur
furthermor
ium
bromid
assay
test
hypothesi
select
compound
repres
divers
molecular
dock
favor
activ
site
sarscov
pro
figur
consist
vitro
cleavag
blocker
variou
biolog
pathway
crucial
sarscov
infect
screen
molecul
tardata
indic
novel
nonpeptid
inhibitor
sarscov
pro
sinc
sarscov
pro
share
gete
viral
entri
transcript
proteolyt
process
three
major
process
essenti
sucsimilar
structur
fold
serin
proteas
test
inhibitori
activ
human
neutrocess
viral
replic
host
phil
elastas
hne
use
azocasein
substrat
demonstr
fail
inhibit
compound
target
sarscov
pro
sarscov
pro
believ
play
major
role
proteoth
proteolyt
activ
hne
figur
suggest
gener
proteas
inhibitor
lytic
process
viral
polyprotein
regard
prime
target
antisarscov
drug
develop
recent
avail
crystal
structur
compound
target
sarscov
hel
identifi
compound
interfer
viral
composarscov
pro
make
suitabl
target
structurebas
ration
drug
design
clone
sarsnent
essenti
transcript
replic
select
sarscov
hel
previous
cov
pro
e
coli
express
system
obtain
purifi
enzym
examin
select
clone
character
assay
system
demonstr
sarscov
ntpasehelicas
compound
target
vital
compon
viru
highperform
liquid
chromatographi
hplc
base
unstimul
atpas
activ
could
stimul
addit
polynucleotid
particular
assay
use
monitor
vitro
cleavag
activ
nate
exhibit
substanti
inhibitori
activ
gml
found
strongli
inhibit
polynucleotidestimul
atpas
activ
sarscov
hel
ic
figur
bare
inhibit
dt
function
conform
helicas
like
nucleic
acidbound
state
initi
unstimul
atpas
activ
even
concentr
figur
helicas
assay
duplex
screen
activ
compound
polynucleotidestimul
atpas
activ
sarscov
hel
dna
prepar
incorpor
overhang
requir
sarscov
helicas
activ
shorter
strand
duplex
dna
incorpor
p
label
differenti
migrat
duplex
singlestrand
oligonucleotid
could
easili
observ
follow
polyacrylamid
gel
electrophoresi
clearli
seen
concentr
inhibit
helicas
activ
sarscov
hel
concentr
inhibit
helicas
activ
figur
possibl
perform
qualit
assay
system
result
fulli
consist
ic
valu
measur
use
quantit
atpas
assay
furthermor
inhibit
viral
plaqu
format
vero
cell
ec
figur
effect
inhibit
stimul
atpas
activ
togeth
abil
inhibit
helicas
activ
indic
distinct
parallel
pharmacolog
profil
inhibitor
target
herp
simplex
viru
hsv
helicaseprimas
protein
pound
indisput
precis
mode
inhibit
base
concept
chemic
genet
establish
ht
platform
identifi
smallmolecul
novel
inhibitor
current
investig
addit
one
caution
ultim
compound
perturb
pathogen
pathway
sarscov
vero
cell
screen
valid
target
select
chemicalresist
virus
subsequ
identif
structur
divers
smallmolecul
compound
sarscov
infect
cellular
model
identigenet
mutat
confer
resist
phenotyp
fection
novagen
atpas
assay
perform
use
phosphomolybdatemalachit
green
assay
measur
phosphat
releas
deimmedi
plate
incub
hr
ident
condit
cell
fix
ad
ml
formaldehyd
scribe
previous
dt
concentr
nm
use
polynucleotid
stimul
atpas
assay
helicas
agaros
plug
remov
subsequ
cell
stain
crystal
violet
methanol
viral
plaqu
assay
plabel
releas
oligo
thermal
anneal
oligo
count
polioviru
type
use
studi
clinic
isol
patient
